Recce Pharmaceuticals Shares Lift as It Pushes Closer to New Trials
2020 has been a busy year for Recce Pharmaceuticals Ltd [ASX:RCE]. The biotech small-cap has been tirelessly putting their synthetic anti-infectives to the test. However, as with any new medicine or treatment, they must first pass intensive trials...